share_log

Enliven Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ballal Rahul D.

SEC ·  Oct 10 17:40
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more